Business

Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer

LADENBURG, Germany - November 24, 2025 (NEWMEDIAWIRE) - Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announced that the Supervisory Board has revoked the appointme...

Heidelberg Pharma AgNovember 24, 20254
Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer

About this update from Heidelberg Pharma Ag

View the original release on www.newmediawire.com

View stock analysis, news, and events for Heidelberg Pharma Ag

Supervisory BoardChief Executive OfficerDr LiuDr Dongzhou Jeffery LiuADC technologyDr Jeffery LiuProfessor Andreas PahlHeidelberg PharmaHeidelberg

More from Heidelberg Pharma Ag

All Heidelberg Pharma Ag news →